====== National Institute of Allergy and Infectious Diseases ======

{{ ::niaid_logo.jpeg?200|}}

The **National Institute of Allergy and Infectious Diseases (NIAID)** is an American government agency underneath the [[National Institutes of Health]], which itself operates under the [[United States Department of Health and Human Services]] (HHS).

===== Organization =====

==== Intellectual property ====

NIAID holds patent rights to a modified version of the [[sars-cov-2:spike_protein|SARS-CoV-2 spike protein]], which have been licensed for use in currently available [[COVID-19 vaccines]] including [[mRNA-1273]] and [[BNT162b2]].((Rizvi, Z. (2020, June 25). //The NIH Vaccine.// Public Citizen. http://archive.today/2021.01.01-104304/https://www.citizen.org/article/the-nih-vaccine/)) The associated patents are:((Petrik, A. (2022, April 28). //Prefusion Coronavirus Spike Proteins and Their Use.// NIH Technology Transfer. https://web.archive.org/web/20230301012116/https://www.techtransfer.nih.gov/tech/tab-3532)) ((Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). //Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.// Science, 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507))

  * [[https://web.archive.org/web/20230301022706/https://patentimages.storage.googleapis.com/c9/24/5d/2b939d2c06ba21/WO2018081318A1.pdf|Prefusion Coronavirus Spike Proteins and Their Use]]
  * 62/972,886
  * PCT/US2021/017709
  * US Application 17/798,021

The inventors listed on these patents within NIAID are financial beneficiaries of their use, presenting a conflict of interest between NIAID and pharmaceutical companies including [[pharmaceutical_companies:Moderna]] and [[pharmaceutical_companies:Pfizer]].((//COVID-19 Vaccines: Dr. Fauci’s Team May Personally Profit.// (2020, October 11). ICAN - Informed Consent Action Network. http://archive.today/2023.03.01-015445/https://icandecide.org/article/covid-19-vaccines-dr-faucis-team-may-personally-profit/))

In May 2022, NIAID licensed various [[COVID-19]]-related technologies to the [[World Health Organization]]'s [[COVID-19 Technology Access Pool]] (C-TAP).((//NIH Contributions to WHO COVID-19 Technology Access Pool and Q&As | Technology Transfer.// (2022, May 12). National Institutes of Health. https://web.archive.org/web/20230301014813/https://www.techtransfer.nih.gov/policy/ctap)) ((//US NIH licenses to C-TAP.// World Health Organization. Retrieved March 1, 2023, from https://web.archive.org/web/20230301024934/https://www.who.int/initiatives/covid-19-technology-access-pool/us-nih-licenses))